Skip to main content

HIV Prevention: Treatment as Prevention (TasP), Occupational Postexposure Prophylaxis (oPEP), Nonoccupational Postexposure Prophylaxis (nPEP), and Pre-exposure Prophylaxis (PrEP)

  • Chapter
  • First Online:
Book cover HIV/AIDS in Rural Communities

Abstract

In this chapter, we review selected literature reflecting on biomedical interventions that prevent HIV infection, and regarding treatment as prevention (TasP), also assist those living with HIV given its goal to effectively reduce infectivity by reducing people living with HIV’s viral load to an undetectable level. Unfortunately, in context to rural health care, little empirical data exists on these interventions, as standalone or combined approaches. What we know about TasP, occupational postexposure prophylaxis (oPEP), nonoccupational postexposure prophylaxis (nPEP), and pre-exposure prophylaxis (PrEP) is that they work, at least in clinical trials they worked. Theoretically, each poses significant potential to reduce HIV transmissions in all geographical settings. Realizing their potential in real-world settings, including rural areas, will require more resources that have yet to be allocated for large-scale implementation, especially concerning nPEP and PrEP. Ideally, our response system should consider developing integrated approaches that include all these interventions, in all jurisdictions. All the more critical, it will be essential to mobilize biomedical (e.g. medications and condoms), behavioral (e.g. cleaning needles prior to use or not sharing needles), and structural (e.g. eliminating stigma attached to HIV infection) interventions to achieve large-scale HIV prevention. In sum, since the discovery of HIV over three and a half decades ago, we have gained considerable knowledge that can and has improved our efforts to prevent (and treat) HIV. Now is the time to make this knowledge work to our advantage with a vision to end HIV transmissions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    The 2015 HIV outbreak in Austin, Indiana (a town of ~4000) and pervasively high rates of prescription drug abuse suggests this trend may not hold (O’Malley, 2015).

  2. 2.

    Even with the decline in their rate over the prior decade, African American women remain disproportionately impacted compared to women of other racial backgrounds (60% of women’s HIV cases are African-American) (CDC, 2016a).

  3. 3.

    Texas, Oklahoma, Missouri, Louisiana, Mississippi, Alabama, Tennessee, Kentucky, Georgia, Florida, North and South Carolina, Virginia, Maryland, West Virginia and Delaware.

References

  • Adimora, A. A., Ramirez, C., Schoenbach, V. J., & Cohen, M. (2014). Policies and politics that promote HIV infection in the southern United States. AIDS, 28, 1393–1397.

    Article  PubMed  PubMed Central  Google Scholar 

  • American Federation for AIDS Research [amfAR]. (2016). Statistics—United States. Retrieved from http://www.amfar.org/about-hiv-and-aids/facts-and-stats/statistics–united-states/

  • Annan, S. L. (2006). Sexual violence in rural areas: A review of the literature. Family & Community Health, 29(3), 164–168.

    Article  Google Scholar 

  • AVERT. (2016). Treatment as prevention. Retrieved from https://www.avert.org/professionals/hiv-programming/prevention/treatment-as-prevention

  • Baeten, J., & Celum, C. (2011, July). Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual African men and women: The partners PrEP study. In 6th IAS conference on HIV pathogenesis, treatment and prevention (pp. 17–20). Rome: IAS.

    Google Scholar 

  • Buchbinder, S. P., Glidden, D. V., Liu, A. Y., McMahan, V., Guanira, J. V., Mayer, K. H., … & Grant, R. M. (2014). HIV pre-exposure prophylaxis in men who have sex with men and transgender women: A secondary analysis of a phase 3 randomised controlled efficacy trial. The Lancet Infectious Diseases, 14(6), 468–475.

    Google Scholar 

  • Carrieri, M. P., Bendiane, M. K., Moatti, J. P., & Rey, D. (2006). Access to HIV prophylaxis for survivors of sexual assault: The tip of the iceberg (vol. 11, pp. 391, 2006). Antiviral Therapy, 11(7), 953–953.

    Google Scholar 

  • CDC. (1990). Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR Morbidity and Mortality Weekly Report, 39(RR01), 1–14.

    Google Scholar 

  • CDC. (2011). Surveillance of occupationally acquired HIV/AIDS in healthcare personnel, as of December 2010. Retrieved from http://www.cdc.gov/HAI/organisms/hiv/Surveillance-Occupationally-Acquired-HIV-AIDS.html

  • CDC. (2015a). HIV in the Southern United States. Retrieved from http://www.cdc.gov/hiv/pdf/policies/cdc-hiv-in-the-south-issue-brief.pdf

  • CDC. (2015b). HIV cost effectiveness. Retrieved from http://www.cdc.gov/hiv/programresources/guidance/costeffectiveness/index.html

  • CDC. (2016a). Trends in U.S. HIV diagnoses, 2005–2014. Retrieved from http://www.cdc.gov/nchhstp/newsroom/docs/factsheets/hiv-data-trends-fact-sheet-508.pdf

  • CDC. (2016b). Lifetime risk of HIV diagnosis. Retrieved from http://www.cdc.gov/nchhstp/newsroom/2016/croi-press-release-risk.html

  • CDC. (2016c). PrEP. Retrieved from http://www.cdc.gov/hiv/basics/prep.html

  • CDC. (2016d). Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016. Retrieved from http://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf

  • CDC. (n.d.). HIV surveillance in urban and nonurban areas through 2013. Retrieved from www.cdc.gov/hiv/ppt/2013-Urban-Nonurban-slides_508-REV-5.pptx

  • Centers for Disease Control [CDC]. (1981). Pneumocystis pneumonia — Los Angeles. Morbidity and Mortality Weekly Report, 30(21), 1–3. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/june_5.htm

  • Chan, P. A., Mena, L., Patel, R., Oldenburg, C. E., Beauchamps, L., Perez-Brumer, A. G., … & Nunn, A. (2016). Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. Journal of the International AIDS Society, 19(1).

    Google Scholar 

  • Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., … & Chuachoowong, R. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 381(9883), 2083–2090.

    Google Scholar 

  • Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … & Godbole, S. V. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505.

    Google Scholar 

  • Cohen, M. S., McCauley, M., & Gamble, T. R. (2012). HIV treatment as prevention and HPTN 052. Current Opinion in HIV and AIDS, 7(2), 99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Connor, E. M., Sperling, R. S., Gelber, R., Kiselev, P., Scott, G., O’Sullivan, M. J., … & Jimenez, E. (1994). Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine, 331(18), 1173–1180.

    Google Scholar 

  • Denning, P., & DiNenno, E. (2015). Communities in crisis: Is there a generalized HIV epidemic in impoverished urban areas of the United States? Retrieved from http://www.cdc.gov/hiv/group/poverty.html

  • Fulton County Task Force on HIV/AIDS. (2015). Phase I progress report: Building the strategy to end AIDS in Fulton County. Retrieved from http://www.sisterlove.org/wp-content/uploads/2014/10/2015-1201-Strategy-to-End-AIDS-in-Fulton-County-Phase-I.pdf

  • Georgia Department of Public Health. (n.d. a). HIV surveillance fact sheet, 2013. Retrieved from http://dph.georgia.gov/sites/dph.georgia.gov/files/HIV_EPI_Fact_Sheet_Surveillance_2013.pdf

  • Georgia Department of Public Health. (n.d. b). HIV surveillance summary, Georgia 2013. Retrieved from http://dph.georgia.gov/sites/dph.georgia.gov/files/HIV_EPI_2013_Surveillance_Summary.pdf

  • Gilliam, B. L., Dyer, J. R., Fiscus, S. A., Marcus, C., Zhou, S., Wathen, L., … & Eron Jr, J. J. (1997). Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen. JAIDS Journal of Acquired Immune Deficiency Syndromes, 15(1), 54–60.

    Google Scholar 

  • Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … & Montoya-Herrera, O. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599.

    Google Scholar 

  • Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., … & Buchbinder, S. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. The Lancet infectious diseases, 14(9), 820–829.

    Google Scholar 

  • Hall, H. I., Li, J., & McKenna, M. T. (2005). HIV in predominantly rural areas of the United States. The Journal of Rural Health, 21(3), 245–253.

    Article  PubMed  Google Scholar 

  • Heckman, T. G., Somlai, A. M., Peters, J., Walker, J., Otto-Salaj, L., Galdabini, C. A., et al. (1998). Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care, 10(3), 365–375.

    Article  CAS  PubMed  Google Scholar 

  • Kaplan, J. E., Dominguez, K., Jobarteh, K., & Spira, T. J. (2015). Postexposure prophylaxis against human immunodeficiency virus (HIV): New guidelines from the WHO: A perspective. Clinical Infectious Diseases, 60(suppl 3), S196–S199.

    Article  PubMed  Google Scholar 

  • Kempf, M. C., McLeod, J., Boehme, A. K., Walcott, M. W., Wright, L., Seal, P., … & Moneyham, L. (2010). A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: Implications for targeted interventions. AIDS Patient Care and STDs, 24(8), 515–520.

    Google Scholar 

  • Kumar, R. S. (2008). Post exposure prophylaxis in HIV. Oral Hypoglycemic Agents: Where Do We Stand Today? 18, 752.

    Google Scholar 

  • Lieb, S., Thompson, D. R., Misra, S., Gates, G. J., Duffus, W. A., Fallon, S. J., … & Southern AIDS Coalition MSM Project Team. (2009). Estimating populations of men who have sex with men in the southern United States. Journal of Urban Health, 86(6), 887–901.

    Article  Google Scholar 

  • McCausland, J. B., Linden, J. A., Degutis, L. C., Ramanujam, P., Sullivan, L. M., & D’Onofrio, G. (2003). Nonoccupational postexposure HIV prevention: Emergency physicians’ current practices, attitudes, and beliefs. Annals of Emergency Eedicine, 42(5), 651–656.

    Article  Google Scholar 

  • Molina, J. M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., … & Raffi, F. (2015). On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine, 373(23), 2237–2246.

    Google Scholar 

  • Montaner, J. S., Hogg, R., Wood, E., Kerr, T., Tyndall, M., Levy, A. R., et al. (2006). The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. The Lancet, 368(9534), 531–536.

    Article  Google Scholar 

  • National Rural Health Association. (n.d.). HIV/AIDS in rural America: Disproportionate impact on minority and multicultural populations. Retrieved fromfile:///C:/Users/necarnes/Downloads/HIVAIDSRuralAmericapolicybriefApril2014%20(2).pdf

  • O’Malley, J. (2015, April 24). Indiana HIV outbreak, hepatitis C epidemic sparks CDC alert. The Indianapolis Star. Retrieved from http://www.indystar.com/story/news/2015/04/24/indiana-hiv-outbreak-hepatitis-epidemic-sparks-cdc-alert/26310539/

  • Ohl, M. E., & Perencevich, E. (2011). Frequency of human immunodeficiency virus (HIV) testing in urban versus rural areas of the United States: Results from a nationally-representative sample. BMC Public Health, 11(1), 1.

    Article  Google Scholar 

  • Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., … & Holmberg, S. D. (1998). HIV Outpatient Study Investigators Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338(13), 853–860.

    Google Scholar 

  • Pinkerton, S. D., Holtgrave, D. R., & Bloom, F. R. (1998). Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. AIDS, 12, 1067–1078.

    Article  CAS  PubMed  Google Scholar 

  • Pinkerton, S. D., Martin, J. N., Roland, M. E., Katz, M. H., Coates, T. J., & Kahn, J. O. (2004). Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus. Archives of Internal Medicine, 164(1), 46–54.

    Article  PubMed  Google Scholar 

  • Preston, D. B., D’Augelli, A. R., Kassab, C. D., & Cain, R. E. (2004). The influence of stigma on the sexual risk behavior of rural men who have sex with men. AIDS Education and Prevention, 16(4), 291.

    Article  PubMed  Google Scholar 

  • Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., … & Gray, R. H. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. New England Journal of Medicine, 342(13), 921–929.

    Google Scholar 

  • Reif, S., Golin, C. E., & Smith, S. R. (2005). Barriers to accessing HIV/AIDS care in North Carolina: Rural and urban differences. AIDS Care, 17(5), 558–565.

    Article  CAS  PubMed  Google Scholar 

  • Reif, S. S., Whetten, K., Wilson, E. R., McAllaster, C., Pence, B. W., Legrand, S., et al. (2014). HIV/AIDS in the Southern USA: A disproportionate epidemic. AIDS Care, 26(3), 351–359.

    Article  PubMed  Google Scholar 

  • Rodriguez, A., Castel, A. D., Parish, C. L., Willis, S., Feaster, D. J., Kharfen, M., … & Metsch, L. R. (2013). HIV medical providers’ perceptions of the use of antiretroviral therapy as non-occupational post-exposure prophylaxis (nPEP) in two major metropolitan areas. Journal of Acquired Immune Deficiency Syndromes (1999), 64(0 1).

    Google Scholar 

  • Rural Center for AIDS/STD Prevention. (2009). HIV/AIDS in rural America: Challenges and promising strategies. Retrieved from http://www.indiana.edu/~aids/factsheets/factsheet23.pdf

  • Schreiner, M. C., Stingl, G., Rieger, A., & Jalili, A. (2013). P4. 049 lopinavir/ritonavir in combination with tenofovir/emtricitabine as post exposure prophylaxis (PEP) to HIV-an effective and well tolerated regimen. Sexually Transmitted Infections, 89(Suppl 1), A303–A304.

    Article  Google Scholar 

  • Sowell, R. L., Lowenstein, A., Moneyham, L., Demi, A., Mizuno, Y., & Seals, B. F. (1997). Resources, stigma, and patterns of disclosure in rural women with HIV infection. Public Health Nursing, 14(5), 302–312.

    Article  CAS  PubMed  Google Scholar 

  • Sutton, M., Anthony, M. N., Vila, C., McLellan-Lemal, E., & Weidle, P. J. (2010). HIV testing and HIV/AIDS treatment services in rural counties in 10 southern states: Service provider perspectives. The Journal of Rural Health, 26(3), 240–247.

    Article  PubMed  Google Scholar 

  • Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., … & Mutanhaurwa, R. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434.

    Google Scholar 

  • U.S. Department of Agriculture. (2015). Rural poverty and well-being. Retrieved from http://www.ers.usda.gov/topics/rural-economy-population/rural-poverty-well-being/geography-of-poverty.aspx

  • U.S. Public Health Service. (2014). Preexposure Prophylaxis for the prevention of HIV infection in the United States—2014 clinical practice guideline. Retrieved from http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf

  • Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., … & Temu, L. (2012). Preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 367(5), 411–422.

    Google Scholar 

  • Vyavaharkar, M., Glover, S., Leonhirth, D., & Probst, J. (2013). HIV/AIDS in rural America: Prevalence and service availability. Retrieved from http://rhr.sph.sc.edu/report/%2811-1%29HIV%20AIDS%20in%20Rural%20America.pdf

  • World Health Organization [WHO]. (n.d.). Global health observatory (GHO) data—HIV/AIDS. Retrieved from http://www.who.int/gho/hiv/en/

  • Yannessa, J. F., Reece, M., & Basta, T. B. (2008). HIV provider perspectives: The impact of stigma on substance abusers living with HIV in a rural area of the United States. AIDS Patient Care and STDs, 22(8), 669–675.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jordan Helms .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Carnes, N.A., Malone, J., Helms, J. (2017). HIV Prevention: Treatment as Prevention (TasP), Occupational Postexposure Prophylaxis (oPEP), Nonoccupational Postexposure Prophylaxis (nPEP), and Pre-exposure Prophylaxis (PrEP). In: Parks, F., Felzien, G., Jue, S. (eds) HIV/AIDS in Rural Communities. Springer, Cham. https://doi.org/10.1007/978-3-319-56239-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56239-1_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56238-4

  • Online ISBN: 978-3-319-56239-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics